Cyclophosphamide as a first-line therapy in LGL leukemia

A. Moignet; Z. Hasanali; R. Zambello; L. Pavan; B. Bareau; O. Tournilhac; Mikaël Roussel; T. Fest; A. Awwad; K. Baab; G. Semenzato; R. Houot; T. P. Loughran; T. Lamy

doi:10.1038/leu.2013.359

Journal articles

Cyclophosphamide as a first-line therapy in LGL leukemia

A. Moignet ¹ Z. Hasanali ² R. Zambello ³ L. Pavan ³ B. Bareau ⁴ O. Tournilhac ⁵ Mikaël Roussel ¹ T. Fest ^{1, 6} A. Awwad ² K. Baab ² G. Semenzato ³ R. Houot ^{1, 6} T. P. Loughran ² T. Lamy ^{1, 6}

1 CHU Pontchaillou [Rennes]

2 Milton S. Hershey Medical Center

3 Universita degli Studi di Padova

4 Department of Clinical Hematology

5 CHU Clermont-Ferrand

6 CIC - Centre d'Investigation Clinique [Rennes]

Keywords : Adult Aged 80 and over Antineoplastic Agents Alkylating Cyclophosphamide Female Humans Leukemia Large Granular Lymphocytic Male Middle Aged

Document type :

Journal articles

Domain :

Life Sciences [q-bio]

Complete list of metadata

Cited literature [18 references] Display Hide Download

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01147023
Contributor : Laurent Jonchère Connect in order to contact the contributor
Submitted on : Monday, June 29, 2015 - 11:28:09 AM
Last modification on : Wednesday, September 7, 2022 - 4:45:15 PM
Long-term archiving on: : Wednesday, September 16, 2015 - 1:55:57 AM

Cyclophosphamide as a first-line therapy in LGL leukemia

File

Identifiers

Collections

Citation

Export

Metrics

93

287

Cyclophosphamide as a first-line therapy in LGL leukemia

File

Identifiers

Collections

Citation

Export

Share

Metrics

93

287